New York S05303 authorizes medical use of psilocybin for certain conditions and prohibits criminal diversion.
New York S05303, known as the "medical psilocybin act," allows the use of psilocybin to treat specific medical conditions, including major treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. The bill establishes a program for the medical use of psilocybin, including criteria for qualified patients, licensed healthcare providers, and qualified supervisors.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.